HU308, A Selective Cannabinoid Type-2 Receptor Agonist, Mitigates SARS-CoV-2 Spike Protein-Induced Acute Lung Injury in Mice Article

sustainable development goals

publication date

  • February 9, 2026

webpage

published in

keywords

  • Acute lung injury
  • Cannabinoid-2 receptor
  • Cannabinoids
  • SARS-CoV-2 spike protein subunit 1

volume

  • 204

issue

  • 1